Area of research
Biomedical Engineering · Pulmonary and Respiratory Medicine · organoid drug screen
Research interest
Research interests include Nanoplatforms for cancer theranostics, Brain Metastases and Treatment, Glioma Diagnosis and Treatment, and MicroRNA in disease regulation.
Noncancerous disease-targeting AIEgens
Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas
Three-staged tumor inhibition by mitochondria-targeted cascaded gas/mild-photothermal/photodynamic synergistic therapy
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial
Borophene-based biomedical applications: Status and future challenges
Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy
Delivery of siRNA targeting HIF-1α loaded chitosan modified<scp>d</scp>-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin